Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden · Delayed Price · Currency is SEK 6.07
+0.46 (8.20%)
May 4, 2026, 5:29 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 2.4 billion as of May 4, 2026. Its market cap has increased by 68.82% in one year.
Market Cap
2.40B
Enterprise Value
2.33B
Revenue
63.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.07
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 2.40B, an increase of 966.58%. That is a compound annual growth rate of 17.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 2.22B | 5.06% |
| Dec 30, 2025 | 2.11B | -16.09% |
| Dec 30, 2024 | 2.51B | 54.03% |
| Dec 29, 2023 | 1.63B | 7.15% |
| Dec 30, 2022 | 1.52B | 37.56% |
| Dec 30, 2021 | 1.11B | -10.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 2.81B |
| Hansa Biopharma AB | 2.77B |
| Flerie AB | 2.26B |
| Saniona AB | 1.93B |
| BioInvent International AB | 1.44B |
| Genovis AB (publ.) | 1.28B |
| Xspray Pharma AB | 1.11B |
| Medivir AB | 1.03B |